25 January 2018 | News
KSDPL is undergoing modernisation to enhance its capacity and quality.
Image credit- medicalxpress.com
Kerela State Drugs and Pharmaceuticals Ltd (KSPDL) has recently received the Good Manufacturing Practice (GMP) certification from the World Health Organisation (WHO), and now the company is eligible to sell its medicines in the world market.
The WHO accords GMP approval for maintaining international safety and quality standards in drug production.
KSDPL is undergoing modernisation to enhance its capacity and quality. Currently, the company is supplying medicines to Andhra Pradesh and Telangana, and Jan Aushadhi.
The LDF government has allocated Rs. 32 crore for implementing various development projects in KSDPL. A Non-Beta Lactam and an injection plants are nearing completion.
The company produces around 50 varieties of medicines, including capsules, tablets, liquids, and powder. It has been mainly supplying medicines to the Kerala State Medical Service Corporation Limited (KSMSCL).